177 results
Page 5 of 9
8-K
EX-10.1
gxt0lp 7czo
10 Dec 20
Alkermes Announces Strategic Value Enhancement Plan and Continued Board Refreshment
7:19am
8-K
EX-99.1
tyvlj 6z2wsgszjqgw
17 Nov 20
Alkermes Receives FDA Complete Response Letter Related to ALKS 3831 Manufacturing Records Review
7:15am
8-K
EX-99.2
rrl 3keow5j
29 Oct 20
Alkermes plc Reports Third Quarter 2020 Financial Results and Raises 2020 Financial Expectations
7:06am
8-K
EX-99.1
tu3b4caj1v04 5hn
29 Oct 20
Alkermes plc Reports Third Quarter 2020 Financial Results and Raises 2020 Financial Expectations
7:06am
8-K
EX-99.1
h7spro7c
29 Jul 20
Alkermes plc Reports Second Quarter 2020 Financial Results and Issues 2020 Financial Expectations
7:08am
8-K
EX-99.2
ccpg5kwhajgy6
29 Jul 20
Alkermes plc Reports Second Quarter 2020 Financial Results and Issues 2020 Financial Expectations
7:08am
DEFA14A
kiwxuc5d0qjvbnugaj
12 May 20
Additional proxy soliciting materials
4:10pm
8-K
EX-99.1
q1krn5
29 Apr 20
Alkermes Plc Reports First Quarter 2020 Financial Results and Provides COVID-19 Related Business Update
7:05am
8-K
EX-99.2
xuk2l1tw1uvx6sbj0oq5
29 Apr 20
Alkermes Plc Reports First Quarter 2020 Financial Results and Provides COVID-19 Related Business Update
7:05am
DEFA14A
l2e87s
3 Apr 20
Additional proxy soliciting materials
5:17pm
8-K
EX-2.1
x7smqte
25 Nov 19
Alkermes Completes Acquisition of Rodin Therapeutics
5:26pm
8-K
EX-99.1
fsjb yxqx33gz
23 Oct 19
Alkermes Plc Reports Third Quarter 2019 Financial Results and Implementation of Restructuring
7:05am